)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
AngioDynamics
AngioDynamics (ANGO) investor relations material
AngioDynamics 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.44th Annual J.P. Morgan Healthcare Conference summary14 Jan, 2026
Strategic transformation and portfolio evolution
Shifted from legacy interventional radiology to a science-driven MedTech portfolio, divesting non-core assets and focusing on high-growth, addressable markets.
MedTech segment now comprises over 45% of revenue, expected to surpass 50% by FY 2027, with a 25% CAGR from FY20 to FY25.
Active portfolio management and increased R&D investment have driven accelerated growth and improved margins since 2020, with streamlined operations.
Internal R&D and platform expansion prioritized over M&A, with significant TAM growth opportunities in BPH, DVT, and coronary markets.
Portfolio optimization may continue, with legacy device assets potentially divested as MedTech gains critical mass.
Product innovation and market performance
Auryon, launched in 2020, has surpassed $200M in cumulative sales, is used in nearly 150,000 procedures, and has grown to over $60M in annual revenue, taking share from major competitors.
AlphaVac and AngioVac offer minimally invasive solutions for venous thromboembolism, with AlphaVac FDA-cleared for pulmonary embolism after the APEX-AV study showed superior clot reduction.
NanoKnife, the only FDA-cleared IRE device for prostate tissue, provides function-preserving therapy for prostate cancer, with strong clinical data from the PRESERVE study showing high efficacy and low side effects.
NanoKnife was recognized as a top medical innovation by TIME in 2025 and featured in AARP campaigns, boosting national visibility.
All platforms are positioned for further expansion into adjacent markets, leveraging existing technology.
Market opportunities and recognition
The company targets large, underpenetrated markets: $800M for PAD, $5.5B for VTE, and $930M for prostate cancer, with significant growth potential as clinical data unlocks new indications.
AlphaVac's competitive edge in VTE market share
NanoKnife's strategy to accelerate prostate market
Capital allocation for future MedTech TAM expansion
Detail platform-based TAM expansion plans
Explain H2 EBITDA generation pace
Address Med Device segment's impact on valuation
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next AngioDynamics earnings date
Q3 20261 Apr, 2026
AngioDynamics
Next AngioDynamics earnings date
Q3 20261 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for use by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings in the United States and internationally. The company operates through four segments: Vascular Access, Peripheral Vascular, Oncology/Surgery, and Venous Therapies. The Peripheral Vascular segment primarily offers radiofrequency ablation systems to ablate or destroy undesired tissue; angiographic products to access the vasculature; thrombolytic products to treat clots; embolization products to block blood flow to a tumor; vena cava filters to trap clot before it can travel to the lungs; dialysis catheters used in hemodialysis procedures; and a range of products used in minimally-invasive, image-guided procedures.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage